TrueBlue, Inc.
TBI · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.27 | 1.53 | -0.11 |
| FCF Yield | -16.26% | 0.72% | 13.96% | -1.51% |
| EV / EBITDA | -84.03 | 41.89 | 5.49 | 10.21 |
| Quality | ||||
| ROIC | -25.04% | -2.32% | 7.65% | 7.15% |
| Gross Margin | 25.93% | 26.55% | 26.71% | 25.78% |
| Cash Conversion Ratio | 0.14 | -2.45 | 1.94 | 0.33 |
| Growth | ||||
| Revenue 3-Year CAGR | -11.41% | -4.28% | 6.88% | -2.83% |
| Free Cash Flow Growth | -1,284.85% | -96.13% | 717.03% | -111.61% |
| Safety | ||||
| Net Debt / EBITDA | -12.43 | -0.05 | -0.08 | 0.18 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 37.54 | 35.89 | 33.95 | 41.97 |